HomeCLRB • NASDAQ
add
Cellectar Biosciences Inc
Previous close
$3.16
Day range
$3.16 - $3.32
Year range
$1.43 - $4.45
Market cap
116.51M USD
Avg Volume
748.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.00M | 37.86% |
Net income | -21.58M | -151.50% |
Net profit margin | — | — |
Earnings per share | -0.74 | 2.63% |
EBITDA | -11.91M | -37.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 40.03M | 215.64% |
Total assets | 42.91M | 189.17% |
Total liabilities | 16.74M | 123.11% |
Total equity | 26.17M | — |
Shares outstanding | 35.85M | — |
Price to book | 11.70 | — |
Return on assets | -109.14% | — |
Return on capital | -231.59% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -21.58M | -151.50% |
Cash from operations | -13.36M | -86.00% |
Cash from investing | -21.63K | — |
Cash from financing | 43.85M | 1,461,648,800.00% |
Net change in cash | 30.47M | 524.10% |
Free cash flow | -4.57M | -12.38% |
About
Founded
1996
Headquarters
Website
Employees
20